← Open Payments lookup

ALI GRIFFIN: Open Payments

NPI 1144643669 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,767 in 154 payments from 19 companies in 2025. Trend: 2023 $2,220 · 2024 $2,250 · 2025 $3,767

Food & beverage: $3,767
CompanyPaymentsAmount
ABBVIE INC.37$707
Madrigal Pharmaceuticals16$599
GENZYME CORPORATION8$266
QOL Medical, LLC8$264
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$249
Takeda Pharmaceuticals U.S.A., Inc.17$246
Janssen Biotech, Inc.13$246
Phathom Pharmaceuticals, Inc.11$242
Ardelyx, Inc.6$236
Lilly USA, LLC6$144

Products named: REZDIFFRA, DUPIXENT, SKYRIZI, Sucraid, XIFAXAN, TREMFYA, VOQUEZNA, IBSRELA.

Industry payments across MD — which companies pay providers there.